FAM222B
geneOn this page
Also known as FLJ10700
Summary
FAM222B (family with sequence similarity 222 member B, HGNC:25563) is a protein-coding gene on chromosome 17q11.2, encoding Protein FAM222B (Q8WU58).
Located in nucleoplasm.
Source: NCBI Gene 55731 — RefSeq curated summary.
At a glance
- GWAS associations: 11
- Clinical variants (ClinVar): 85 total
- Druggable target: yes
- MANE Select transcript:
NM_001077498
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25563 |
| Approved symbol | FAM222B |
| Name | family with sequence similarity 222 member B |
| Location | 17q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10700 |
| Ensembl gene | ENSG00000173065 |
| Ensembl biotype | protein_coding |
| Entrez | 55731 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 33 protein_coding, 1 nonsense_mediated_decay
ENST00000341217, ENST00000452648, ENST00000577376, ENST00000577513, ENST00000577682, ENST00000579381, ENST00000581229, ENST00000581407, ENST00000582059, ENST00000582266, ENST00000583307, ENST00000583522, ENST00000583953, ENST00000584059, ENST00000874874, ENST00000874875, ENST00000874876, ENST00000874877, ENST00000874878, ENST00000874879, ENST00000874880, ENST00000919307, ENST00000919308, ENST00000919309, ENST00000919310, ENST00000919311, ENST00000919312, ENST00000919313, ENST00000919314, ENST00000919315, ENST00000919316, ENST00000919317, ENST00000919318, ENST00000919319
RefSeq mRNA: 12 — MANE Select: NM_001077498
NM_001077498, NM_001288631, NM_001288632, NM_001288633, NM_001288634, NM_001288635, NM_001288636, NM_001288637, NM_001288638, NM_001288639, NM_001288640, NM_018182
CCDS: CCDS45637
Canonical transcript exons
ENST00000581407 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002698491 | 28842682 | 28842790 |
| ENSE00002713974 | 28755980 | 28759876 |
| ENSE00003919538 | 28766586 | 28766707 |
Expression profiles
Bgee: expression breadth ubiquitous, 279 present calls, max score 97.50.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.8610 / max 175.0210, expressed in 1807 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165079 | 13.0410 | 1792 |
| 165077 | 4.7679 | 1562 |
| 165076 | 0.3450 | 159 |
| 165078 | 0.2327 | 89 |
| 165080 | 0.2034 | 80 |
| 165073 | 0.1325 | 60 |
| 208113 | 0.1217 | 41 |
| 165081 | 0.0168 | 4 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 97.50 | gold quality |
| oocyte | CL:0000023 | 96.20 | gold quality |
| secondary oocyte | CL:0000655 | 95.96 | gold quality |
| male germ cell | CL:0000015 | 95.76 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 95.61 | silver quality |
| tibialis anterior | UBERON:0001385 | 91.28 | silver quality |
| nipple | UBERON:0002030 | 91.02 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.85 | gold quality |
| renal medulla | UBERON:0000362 | 90.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 90.56 | gold quality |
| cerebellar vermis | UBERON:0004720 | 90.55 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 90.12 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 90.04 | gold quality |
| pylorus | UBERON:0001166 | 89.94 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 89.77 | gold quality |
| cardia of stomach | UBERON:0001162 | 89.57 | gold quality |
| ventral tegmental area | UBERON:0002691 | 89.28 | gold quality |
| visceral pleura | UBERON:0002401 | 89.26 | gold quality |
| muscle of leg | UBERON:0001383 | 89.17 | gold quality |
| ileal mucosa | UBERON:0000331 | 88.64 | silver quality |
| epithelium of mammary gland | UBERON:0003244 | 88.35 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 88.33 | gold quality |
| trachea | UBERON:0003126 | 88.22 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 88.16 | gold quality |
| body of tongue | UBERON:0011876 | 88.14 | gold quality |
| mammary duct | UBERON:0001765 | 88.03 | gold quality |
| testis | UBERON:0000473 | 87.99 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 87.98 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 87.91 | gold quality |
| left testis | UBERON:0004533 | 87.87 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.76 |
| E-CURD-10 | no | 237.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
189 targeting FAM222B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam222ba | ENSDARG00000059886 |
| danio_rerio | fam222bb | ENSDARG00000078578 |
| mus_musculus | Fam222b | ENSMUSG00000037750 |
| rattus_norvegicus | Fam222b | ENSRNOG00000029570 |
Paralogs (1): FAM222A (ENSG00000139438)
Protein
Protein identifiers
Protein FAM222B — Q8WU58 (reviewed: Q8WU58)
All UniProt accessions (7): Q8WU58, J3KSK8, J3QKY8, J3QLP2, J3QR32, J3QRM5, J3QRR9
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM222 family.
RefSeq proteins (12): NP_001070966, NP_001275560, NP_001275561, NP_001275562, NP_001275563, NP_001275564, NP_001275565, NP_001275566, NP_001275567, NP_001275568, NP_001275569, NP_060652 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029340 | FAM222 | Family |
Pfam: PF15258
UniProt features (11 total): region of interest 3, sequence conflict 3, compositionally biased region 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WU58-F1 | 48.21 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 132 (showing top):
AAGCAAT_MIR137, PAX4_01, TGCGCANK_UNKNOWN, HATADA_METHYLATED_IN_LUNG_CANCER_DN, chr17q11, YY1_02, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, ACEVEDO_LIVER_CANCER_UP, TGCCTTA_MIR124A, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, ACACTGG_MIR199A_MIR199B, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, MTF1_Q4, DCA_UP.V1_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleoplasm (GO:0005654), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
228 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM222B | PDZD9 | Q8IXQ8 | 642 |
| FAM222B | OR51D1 | Q8NGF3 | 526 |
| FAM222B | ZNF572 | Q7Z3I7 | 489 |
| FAM222B | SSC4D | Q8WTU2 | 484 |
| FAM222B | CEP152 | O94986 | 474 |
| FAM222B | OR2K2 | Q8NGT1 | 463 |
| FAM222B | ZNF789 | Q5FWF6 | 453 |
| FAM222B | TRMT10B | Q6PF06 | 447 |
| FAM222B | ZNF695 | Q8IW36 | 431 |
| FAM222B | FAM177A1 | Q8N128 | 430 |
| FAM222B | THUMPD2 | Q9BTF0 | 430 |
| FAM222B | LMBR1L | Q6UX01 | 390 |
| FAM222B | SLC1A6 | P48664 | 378 |
| FAM222B | BEAN1 | Q3B7T3 | 370 |
| FAM222B | NUFIP2 | Q7Z417 | 360 |
IntAct
116 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM222B | CYSRT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | SPAG8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | SMUG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | EIF3F | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | AKAP8L | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | ANKRD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMUG1 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| EIF3F | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR20D | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| BANP | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL3 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIP6 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP11-1 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TTLL12 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | KRTAP3-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP26-1 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | LRRC61 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ACTMAP | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SOHLH1 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM222B | CNFN | psi-mi:“MI:0915”(physical association) | 0.560 |
| UFSP1 | FAM222B | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (45): FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid), FAM222B (Two-hybrid)
ESM2 similar proteins: A0A096MJY4, A0A1L8H0H2, A1L2P5, A2ICN5, A2VDZ3, A4UTP7, B1AYB6, F8VPJ6, O54826, O94900, P19538, P22199, P23682, P55197, P91607, P91686, P91705, P91943, Q02078, Q03413, Q03414, Q06413, Q1KKS7, Q2KHR2, Q2KIA0, Q2MJT0, Q3LHL9, Q3V5Z9, Q5R444, Q5REW7, Q60929, Q66JW3, Q6P539, Q6YXY2, Q8BUR3, Q8CFN5, Q8VII8, Q8WU58, Q8WYQ9, Q91690
Diamond homologs: Q5U5X8, Q6PGH4, Q8WU58, Q6P539
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 73 |
| Likely benign | 3 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1687 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:28842680:A:AC | donor_gain | 1.0000 |
| 17:28842681:C:CC | donor_gain | 1.0000 |
| 17:28842681:CGGT:C | donor_gain | 1.0000 |
| 17:28759765:C:CC | acceptor_gain | 0.9900 |
| 17:28766584:A:AC | donor_gain | 0.9900 |
| 17:28766585:C:CC | donor_gain | 0.9900 |
| 17:28766585:CATTT:C | donor_gain | 0.9900 |
| 17:28766704:CACA:C | acceptor_gain | 0.9900 |
| 17:28766706:CA:C | acceptor_gain | 0.9900 |
| 17:28766708:C:CC | acceptor_gain | 0.9900 |
| 17:28779108:TAG:T | donor_gain | 0.9900 |
| 17:28790709:T:A | donor_gain | 0.9900 |
| 17:28806435:T:TA | donor_gain | 0.9900 |
| 17:28806470:T:TA | donor_gain | 0.9900 |
| 17:28842676:ACT:A | donor_loss | 0.9900 |
| 17:28842677:C:CG | donor_loss | 0.9900 |
| 17:28842678:T:TG | donor_loss | 0.9900 |
| 17:28842679:C:CG | donor_loss | 0.9900 |
| 17:28842680:A:AG | donor_loss | 0.9900 |
| 17:28842680:ACGGT:A | donor_gain | 0.9900 |
| 17:28842681:C:CT | donor_loss | 0.9900 |
| 17:28842681:CG:C | donor_gain | 0.9900 |
| 17:28842681:CGG:C | donor_gain | 0.9900 |
| 17:28842681:CGGTC:C | donor_gain | 0.9900 |
| 17:28759763:CA:C | acceptor_gain | 0.9800 |
| 17:28766703:TCACA:T | acceptor_gain | 0.9800 |
| 17:28766704:CACAC:C | acceptor_gain | 0.9800 |
| 17:28779109:A:AC | donor_gain | 0.9800 |
| 17:28806431:T:TA | donor_gain | 0.9800 |
| 17:28823106:A:AC | acceptor_gain | 0.9800 |
AlphaMissense
3651 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:28759773:G:C | F62L | 1.000 |
| 17:28759773:G:T | F62L | 1.000 |
| 17:28759774:A:G | F62S | 1.000 |
| 17:28759775:A:G | F62L | 1.000 |
| 17:28759777:A:G | I61T | 1.000 |
| 17:28759783:A:C | I59R | 1.000 |
| 17:28759783:A:T | I59K | 1.000 |
| 17:28759813:G:T | A49D | 1.000 |
| 17:28759825:A:G | L45S | 1.000 |
| 17:28759071:G:C | S296R | 0.999 |
| 17:28759071:G:T | S296R | 0.999 |
| 17:28759073:T:G | S296R | 0.999 |
| 17:28759091:C:G | G290R | 0.999 |
| 17:28759095:A:C | C288W | 0.999 |
| 17:28759096:C:T | C288Y | 0.999 |
| 17:28759097:A:G | C288R | 0.999 |
| 17:28759131:G:C | C276W | 0.999 |
| 17:28759132:C:T | C276Y | 0.999 |
| 17:28759133:A:G | C276R | 0.999 |
| 17:28759144:A:G | I272T | 0.999 |
| 17:28759213:A:C | I249S | 0.999 |
| 17:28759213:A:G | I249T | 0.999 |
| 17:28759213:A:T | I249N | 0.999 |
| 17:28759756:A:T | V68D | 0.999 |
| 17:28759774:A:C | F62C | 0.999 |
| 17:28759777:A:C | I61S | 0.999 |
| 17:28759777:A:T | I61N | 0.999 |
| 17:28759783:A:G | I59T | 0.999 |
| 17:28759789:A:G | L57P | 0.999 |
| 17:28759814:C:G | A49P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000007106 (17:28826133 G>A,C), RS1000024785 (17:28818810 G>A), RS1000095529 (17:28851242 C>A,T), RS1000105876 (17:28803945 C>T), RS1000115745 (17:28817932 T>C), RS1000159003 (17:28800217 C>T), RS1000180763 (17:28842827 G>A), RS1000211162 (17:28828197 G>A,C), RS1000231537 (17:28755526 T>G), RS1000246973 (17:28827828 G>C), RS1000276232 (17:28768167 A>G), RS1000340552 (17:28849177 C>A,T), RS1000354787 (17:28819339 C>T), RS1000364363 (17:28759881 A>G), RS1000386591 (17:28761750 A>G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:619575
GenCC curated gene-disease
Mondo (1): developmental delay with or without intellectual impairment or behavioral abnormalities (MONDO:0859199)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004602_290 | Mean corpuscular volume | 3.000000e-35 |
| GCST004605_21 | Mean corpuscular hemoglobin concentration | 3.000000e-44 |
| GCST004621_188 | Red cell distribution width | 2.000000e-70 |
| GCST004630_212 | Mean corpuscular hemoglobin | 9.000000e-65 |
| GCST006011_47 | Mean corpuscular volume | 4.000000e-09 |
| GCST008837_5 | Estimated glomerular filtration rate reduction (30%) | 9.000000e-06 |
| GCST90002384_408 | Hemoglobin | 1.000000e-16 |
| GCST90002390_108 | Mean corpuscular hemoglobin | 4.000000e-161 |
| GCST90002391_90 | Mean corpuscular hemoglobin concentration | 5.000000e-81 |
| GCST90002392_12 | Mean corpuscular volume | 3.000000e-103 |
| GCST90002403_355 | Red blood cell count | 4.000000e-24 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0009188 | Red cell distribution width |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066370 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.96 | Kd | 110.4 | nM | CHEMBL5653589 |
| 6.74 | ED50 | 180.8 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148363: Binding affinity to human FAM222B incubated for 45 mins by Kinobead based pull down assay | kd | 0.1104 | uM |
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Coumestrol | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, increases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Dronabinol | increases expression | 1 |
| Theophylline | affects cotreatment, increases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651405 | Binding | Binding affinity to human FAM222B incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): developmental delay with or without intellectual impairment or behavioral abnormalities